Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 19, Issue 3, 2016, Pages 171-176

  Sala, David ^a   Sacco, Alessandra ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Muscle stem cells; Muscle wasting; Signal transducer and activator of transcription 3; Skeletal muscle

Indexed keywords

ANTINEOPLASTIC AGENT; ATROGIN 1; AZD 9150; CCAAT ENHANCER BINDING PROTEIN DELTA; DNA METHYLTRANSFERASE 1; HISTONE LYSINE METHYLTRANSFERASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INITIATION FACTOR 2ALPHA; INTERLEUKIN 6; IONIS STAT3RX; MITOGEN ACTIVATED PROTEIN KINASE; MUSCLE RING FINGER 1 PROTEIN; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; OPB 31121; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE R; SORAFENIB; STAT3 ALPHA PROTEIN; STAT3 BETA PROTEIN; STAT3 DECOY; STAT3 DELTA PROTEIN; STAT3 GAMMA PROTEIN; STAT3 PROTEIN; SUNITINIB; TRANSCRIPTION FACTOR EZH2; UBIQUITIN; UNCLASSIFIED DRUG; STAT3 PROTEIN, HUMAN;

CACHEXIA; CELLS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL (TOPIC); HUMAN; MACROPHAGE; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STEM CELL; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SUBUNIT; PSORIASIS; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SKELETAL MUSCLE; STEM CELL SELF-RENEWAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ADULT; ADULT STEM CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF-RENEWAL; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; MUSCLE DEVELOPMENT; MUSCULAR DISORDERS, ATROPHIC; PATHOLOGY; WASTING SYNDROME;

ADULT; ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF RENEWAL; HUMANS; MACROPHAGES; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DISORDERS, ATROPHIC; STAT3 TRANSCRIPTION FACTOR; WASTING SYNDROME;

EID: 84963656297     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000273     Document Type: Review

References (41)

1. Bentzinger CF, Wang YX, Dumont NA, Rudnicki MA. Cellular dynamics in the muscle satellite cell niche. EMBO Rep 2013; 14:1062-1072.
2. Judson RN, Zhang RH, Rossi FM. Tissue-resident mesenchymal stem/progenitor cells in skeletal muscle: collaborators or saboteurs? FEBS J 2013; 280:4100-4108.
3. Rigamonti E, Zordan P, Sciorati C, et al. Macrophage plasticity in skeletal muscle repair. Biomed Res Int 2014; 2014:560629.
4. He WA, Berardi E, Cardillo VM, et al. NF-kappa B-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest 2013; 123:4821-4835.
5. Dumont NA, Wang YX, von Maltzahn J, et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med 2015; 21:1455-1463.
6. Sacco A, Puri PL. Regulation of muscle satellite cell function in tissue homeostasis and aging. Cell Stem Cell 2015; 16:585-587.
7. Garcia-Prat L, Martinez-Vicente M, Perdiguero E, et al. Autophagy maintains stemness by preventing senescence. Nature 2016; 529:37-42.
8. Zhang C, Li Y, Wu Y, et al. Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J Biol Chem 2013; 288:1489-1499.
9. Tierney MT, Aydogdu T, Sala D, et al. STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat Med 2014; 20:1182-1186.
10. Price FD, von Maltzahn J, Bentzinger CF, et al. Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat Med 2014; 20:1174-1181.
11. Lemos DR, Babaeijandaghi F, Low M, et al. Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors. Nat Med 2015; 21:786-794.
12. Uezumi A, Fukada S, Yamamoto N, et al. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 2010; 12:143-152.
13. Joe AW, Yi L, Natarajan A, et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 2010; 12:153-163.
14. Uezumi A, Fukada S, Yamamoto N, et al. Identification and characterization of PDGFRalpha+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis 2014; 5:e1186.
15. Farup J, Madaro L, Puri PL, Mikkelsen UR. Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease. Cell Death Dis 2015; 6:e1830.
16. Saccone V, Consalvi S, Giordani L, et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibroadipogenic progenitors in dystrophic muscles. Genes Dev 2014; 28:841-857.
17. Rollins KE, Tewari N, Ackner A, et al. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr 2015; doi: 10.1016/j.clnu.2015.08.005. [Epub ahead of print]
18. Malietzis G, Johns N, Al-Hassi HO, et al. Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer. Ann Surg 2016; 263:320-325.
19. You L, Wang Z, Li H, et al. The role of STAT3 in autophagy. Autophagy 2015; 11:729-739.
20. Yu H, Lee H, Herrmann A, et al. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 2014; 14:736-746.
21. Nakamura R, Sene A, Santeford A, et al. IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis. Nat Commun 2015; 6:7847.
22. Lee H, Zhang P, Herrmann A, et al. Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci U S A 2012; 109:7765-7769.
23. Kim E, Kim M, Woo DH, et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell 2013; 23:839-852.
24. Dasgupta M, Dermawan JK, Willard B, Stark GR. STAT3-driven transcription depends upon the dimethylation of K49 by EZH2. Proc Natl Acad Sci U S A 2015; 112:3985-3990.
25. Kato T, Sakamoto E, Kutsuna H, et al. Proteolytic conversion of STAT3alpha to STAT3gamma in human neutrophils: role of granule-derived serine proteases. J Biol Chem 2004; 279:31076-31080.
26. Gough DJ, Corlett A, Schlessinger K, et al. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 2009; 324:1713-1716.
27. Wegrzyn J, Potla R, Chwae YJ, et al. Function of mitochondrial Stat3 in cellular respiration. Science 2009; 323:793-797.
28. Demaria M, Camporeale A, Poli V. STAT3 and metabolism: how many ways to use a single molecule? Int J Cancer 2014; 135:1997-2003.
29. Ryall JG, Dell'Orso S, Derfoul A, et al. The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 2015; 16:171-183.
30. Pencik J, Schlederer M, Gruber W, et al. STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun 2015; 6:7736.
31. Pelosi L, Berardinelli MG, De Pasquale L, et al. Functional and morphological improvement of dystrophic muscle by interleukin 6 receptor blockade. EBio-Medicine 2015; 2:285-293.
32. Zhang L, Pan J, Dong Y, et al. Stat3 activation links a C/EBPdelta to myostatin pathway to stimulate loss of muscle mass. Cell Metab 2013; 18:368-379.
33. Silva KA, Dong J, Dong Y, et al. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. J Biol Chem 2015; 290:11177-11187.
34. Gilabert M, Calvo E, Airoldi A, et al. Pancreatic cancer-induced cachexia is Jak2-dependent in mice. J Cell Physiol 2014; 229:1437-1443.
35. Pretto F, Ghilardi C, Moschetta M, et al. Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle. Oncotarget 2015; 6:3043-3054.
36. Yamada E, Bastie CC, Koga H, et al. Mouse skeletal muscle fiber-typespecific macroautophagy and muscle wasting are regulated by a Fyn/STAT3/Vps34 signaling pathway. Cell Rep 2012; 1:557-569.
37. Kim TH, Choi SE, Ha ES, et al. IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetol 2013; 50:189-200.
38. Mashili F, Chibalin AV, Krook A, Zierath JR. Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Diabetes 2013; 62:457-465.
39. White AT, LaBarge SA, McCurdy CE, Schenk S. Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance. Mol Metab 2015; 4:569-575.
40. Aoyagi T, Terracina KP, Raza A, et al. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol 2015; 7:17-29.
41. Sala D, Zorzano A. Differential control of muscle mass in type 1 and type 2 diabetes mellitus. Cell Mol Life Sci 2015; 72:3803-3817.